4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:动物毒液多肽毒素
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > acid_base_buffer_solution > Smartox/钙离子选择性阻滞剂v2.3通道/08SNX001-00050/0.05mg
商品详细Smartox/钙离子选择性阻滞剂v2.3通道/08SNX001-00050/0.05mg
Smartox/钙离子选择性阻滞剂v2.3通道/08SNX001-00050/0.05mg
Smartox/钙离子选择性阻滞剂v2.3通道/08SNX001-00050/0.05mg
商品编号: 08SNX001-00050
品牌: smartox-biotech
市场价: ¥1747.20
美元价: 1344.00
产地: 美国(厂家直采)
公司:
产品分类: 酸碱缓冲液
公司分类: acid_base_buffer_solution
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

SNX-482 hasbeenisolatedfromthevenomoftheSpiderHysterocratesgigas(Africantarantula). SNX-482 modulatestheR-type currentassociatedwiththeclassα1Ecalciumchannel(Cav2.3 fromtheCACNA1Egene). SNX-482 antagonizeschannelactivationbyinducingadepolarizingshiftintheactivationpotential,thuspreventingthechannelfromundergoingnormalmembranedepolarization. SNX-482 actsrapidlyandmaintainsitseffect.


Description:

Productcode:08SNX001.Categories:Calciumchannels,Highvoltage-gatedCa2+channels.Tags:203460-30-4,Cav2.3,r-type.

AAsequence: Gly-Val-Asp-Lys-Ala-Gly-Cys7-Arg-Tyr-Met-Phe-Gly-Gly-Cys14-Ser-Val-Asn-Asp-Asp-Cys20-Cys21-Pro-Arg-Leu-Gly-Cys26-His-Ser-Leu-Phe-Ser-Tyr-Cys33-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp-OH
Disulfidebonds: Cys7-Cys21,Cys14-Cys26 andCys20-Cys33
Length(aa): 41
Formula: C192H274N52O60S7
MolecularWeight: 4496.42Da
Appearance:Whitelyophilizedsolid
Solubility: waterandsalinebuffer
CASnumber: 203460-30-4
Source: Synthetic
Purityrate: >95%

Reference:

TheCav2.3calciumchannelantagoNISTSNX-482reducesdorsalhornneuronalresponsesinaratmodelofchronicneuropathicpain

Neuropathicpainisadifficultstatetotreat,characterizedbyalterationsinsensoryprocessingthatcanincludeallodynia(touch-evokedpain).Evidenceexistsfornervedamage-inducedplasticityinbothtransmission&modulatorysystems,includingchangesinvoltage-dependentcalciumchannel(VDCC)expression&function;however,theroleofCa(v)2.3calciumchannelshasnotclearlybeendefined.Here,theeffectsofSNX-482,aselectiveCa(v)2.3antagonist,onsensorytransmissionatthespinalcordlevelhavebeeninvestigatedintherat.Thespinalnerveligation(SNL)modelofchronicneuropathicpain[Kim&Chung,(1992)Pain,50,355-363]wasusedtoinducemechanicalallodynia,astestedontheipsilateralhindpaw.Invivoelectrophysiologicalmeasurementsofdorsalhornneuronalresponsestoinnocuous&noxiouselectricalandnaturalstimuliweremadeafterSNL&comparedtosham-operatedanimals.SpinalSNX-482(0.5-4microg/50microL)exerteddose-relatedinhibitionsofnoxiousC-fibre-andAdelta-fibre-mediatedneuronalresponsesinconditionsofneuropathy,butnotinsham-operatedanimals.MeasuresofspinalcordhyperexcitABIlity&nociceptionweremostsusceptIBLetoSNX-482.Incontrast,non-noxiousAbeta-mediatedresponseswerenotaffectedbySNX-482.Moreover,responsestoinnocuousmechanical&alsothermalstimuliweremoresensitivetoSNX-482inSNLthancontrolanimals.ThisstudyisthefirsttodemonstrateanantinociceptiveroleforSNX-482-sensitivechannelsindorsalhornneuronsduringneuropathy.ThesedataareconsistentwithplasticityinCa(V)2.3calciumchannelexpressionandsuggestapotentialselectivetargettoreducenociceptivetransmissionduringconditionsofnervedamage.

MatthewsEA., etal.(2007)TheCav2.3calciumchannelantagonistSNX-482reducesdorsalhornneuronalresponsesinaratmodelofchronicneuropathicpain. EurJNeurosci. PMID17610575

SNX482selectivelyblocksP/QCa2+channelsanddelaystheinactivationofNa+channelsofchromaffincells

TheeffectsofthetoxinSXN482onCa2+channelcurrents(ICa),Na+currents(INa),andK+currents(IK)havebeenstudiedinbovineadrenalmedullarychromaffincellsvoltage-clampedat-80mV.Currentswereelicitedbydepolarisingpulsesto0-10mV(ICaandINa)orto+60mV(IK).SNX482blockedICainaconcentration-dependentmanner.Theinhibitioncurveexhibitedtwophases.Thefirsthigh-affinityphasecomprised28%ofthewhole-cellcurrent&exhibitedanIC50of30.2nM.Thesecondlow-affinityphasecomprisedover70%ofICa&hadanIC50of758.6nM.Blockadewasrapidandfullyreversibleuponwashoutofthetoxin.OcclusionexperimentsshowedadditivityofblockadeexertedbynifedipineplusSNX482(0.3microM)andbyomega-conotoxinGVIAplusSNX482.Incontrast,blockadeexertedbycombinedomega-agatoxinIVAplusSNX482(about50%ofthewholecell)didnotshowadditivity.At0.3microMandhigherconcentrations,SNX482delayedtheinactivationofINa.Thetimeconstant(tau)forinactivationofINaincontrolconditionsdoubledinthepresenceof0.5microMSNX482.At0.3microM,SNX482didnotaffectIK.Ourdatademonstratethat:(i)SNX482selectivelyblocksP/QCa2+channelsatsubmicromolarconcentrations;(ii)thetoxinpartiallyblocksNa+channels;(iii)SNX482delaystheinactivationofNa+channels.TheseresultsrevealnovelpropertiesofSNX482andcastdoubtsontheclaimedselectivity&specificityofthetoxintoblocktheR-typeCa2+channel.

ArroyoG, etal.(2003)SNX482selectivelyblocksP/QCa2+channelsanddelaystheinactivationofNa+channelsofchromaffincells, EurJPharmacol. PMID:12954354

InteractionofSNX482withdomainsIIIandIVinhibitsactivationgatingofalpha(1E)(Ca(V)2.3)calciumchannels
WehaveinvestigatedtheactionofSNX482,atoxinisolatedfromthevenomofthetarantulaHysterocratesgigas,onvoltage-dependentcalciumchannelsexpressedintsa-201cells.Uponapplicationof200nMSNX482,R-typealpha(1E)calciumchannelsunderwentrapid&completeinhibition,whichwasonlypoorlyreversibleuponwashout.However,uponapplicationofstrongmembranedepolarizations,rapid&completerecoveryfrominhibitionwasobtained.TailcurrentanalysisrevealedthatSNX482mediatedanapproximately70mVdepolarizingshiftinhalf-activationpotential,suggestingthatthetoxininhibitsalpha(1E)calciumchannelsbypreventingtheiractivation.Experimentsinvolvingchimericchannelscombiningstructuralfeaturesofalpha(1E)andalpha(1C)subunitsindicatedthatthepresenceofthedomainIIIandIVofalpha(1E)isaprerequisiteforastronggatinginhibition.Incontrast,L-typealpha(1C)channelsunderwentincompleteinhibitionatsaturatingconcentrationsofSNX482thatwasparalleledbyasmallshiftinhalf-activationpotentialandwhichcouldberapidlyreversed,suggestingalesspronouncedeffectofthetoxinonL-typecalciumchannelgating.WeconcludethatSNX482doesnotexhibitunequivocalspecificityforR-typechannels,buthighlyeffectivelyantagonizestheiractivation.

Bourinet,E., etal. (2001)InteractionofSNX482withdomainsIIIandIVinhibitsactivationgatingofalpha(1E)(Ca(V)2.3)calciumchannels, Biophys. PMID11423396

SelectivepeptideantagonistoftheclassEcalciumchannelfromthevenomofthetarantulaHysterocratesgigas

WedescribethefirstpotentandselectiveblockeroftheclassECa2+channel.SNX-482,anovel41aminoacidpeptidepresentinthevenomoftheAfricantarantula,Hysterocratesgigas,wasidentifiedthroughitsabilitytoinhibithumanclassECa2+channelsstablyexpressedinamammaliancellline.AnIC50of15-30nMwasobtainedforblockoftheclassECa2+channel,usingeitherpatchclampelectrophysiologyorK+-evokedCa2+flux.Atlownanomolarconcentrations,SNX-482alsoblockedanativeresistantorR-typeCa2+currentinratneurohypophysealnerveterminals,butconcentrationsof200-500nMhadnoeffectonR-typeCa2+currentsinseveraltypesofratcentralneurons.ThepeptidehasthesequenceGVDKAGCRYMFGGCSVNDDCCPRLGCHSLFSYCAWDLTFSD-OHandishomologoustothespiderpeptidesgrammatoxinS1Aandhanatoxin,bothpeptideswithverydifferentionchannelblockingselectivities.NoeffectofSNX-482wasobservedonthefollowingionchannelactivities:Na+orK+currentsinseveralculturedcelltypes(upto500nM);K+currentthroughclonedpotassiumchannelsKv1.1andKv1.4expressedinXenopusoocytes(upto140nM);Ca2+fluxthroughL-andT-typeCa2+channelsinananteriorpituitarycellline(GH3,upto500nM);andBa2+currentthroughclassACa2+channelsexpressedinXenopusoocytes(upto280nM).AweakeffectwasnotedonCa2+currentthroughclonedandstablyexpressedclassBCa2+channels(IC50>500nM).TheuniqueselectivityofSNX-482suggestsitsusefulnessinstudyingthediversity,function,andpharmacologyofclassEand/orR-typeCa2+channels.

Newcomb,R., etal. (1998)SelectivepeptideantagonistoftheclassEcalciumchannelfromthevenomofthetarantulaHysterocratesgigas, Biochemistry. PMID:9799496

品牌介绍
Smartox Biotechnology 是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。Smartox Biotechnology 于 2009 年由来自 Grenoble 神经科学研究所 (Grenoble Institute of Neuroscience) 的 Michel de waard 博士创立, Smartox Biotechnology 专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。 De Waard 博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽 (cell penetrating peptides, CPP) 。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。 2010 年, Smartox Biotechnolgy 被法国研究部 (Ministry of Research) 授予“新兴企业 OSEO 奖 (OSEO prize for emerging businesses) ”。